Corporate DisclosureADVENT
ADVENT Corporate Disclosure — 4 February 2020
Announcement summary
- What happened
- ADVENT published a corporate disclosure on 4 February 2020. Read the full announcement for details.
- Company
- Advent Pharma Limited
- Announcement published
Original announcement
The Company has informed that they have got approval to introduce 11 (Eleven) new products from Directorate General of Drug Administration, where new therapeutic class of 6 Injectables, along with 4 liquid items and 1 bolus item.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b0000400577dd
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ADVENT
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.